Clinical performance and biocompatibility of poly(2-methoxyethylacrylate)—coated extracorporeal circuits Serdar Gunaydin, MD, Bora Farsak, MD, Mustafa.

Slides:

Advertisements

Similar presentations

The effect of cardiotomy suction on the brain injury marker S100β after cardiopulmonary bypass Russell E Anderson, MD, PhD, Lars-Olof Hansson, MD, PhD,

Advertisements

Stress-Dose Corticosteroid Versus Placebo in Neonatal Cardiac Operations: A Randomized Controlled Trial Pertti K. Suominen, MD, PhD, Juho Keski-Nisula,

Antithrombin Administration in Patients With Low Antithrombin Values After Cardiac Surgery: A Randomized Controlled Trial Domenico Paparella, MD, Crescenzia.

Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia Abdellah Aouifi, MD, Pascale Blanc, MD, Vincent.

Changes in cysteinyl leukotrienes during and after cardiac surgery with cardiopulmonary bypass in patients with and without chronic obstructive pulmonary.

Neuromonitoring and neurocognitive outcome in off-pump versus conventional coronary bypass operation Anno Diegeler, MD, Robert Hirsch, MD, Felix Schneider,

Reduction of the Inflammatory Response in Patients Undergoing Minimally Invasive Coronary Artery Bypass Grafting Y.John Gu, Massimo A Mariani, Willem.

Coronary Artery Bypass Grafting in Immune Thrombocytopenic Purpura

Randomized trial of near-infrared spectroscopy for personalized optimization of cerebral tissue oxygenation during cardiac surgery C.A. Rogers, S. Stoica,

Attenuation of Changes in Leukocyte Surface Markers and Complement Activation With Heparin-Coated Cardiopulmonary Bypass Oddvar Moen, MD, Kolbjørn Høgåsen,

Outcome After Rewarming From Accidental Hypothermia by Use of Extracorporeal Circulation Øyvind Sverre Svendsen, MD, PhD, Ketil Grong, MD, PhD, Knut.

Fibrinogen Levels After Cardiac Surgical Procedures: Association With Postoperative Bleeding, Trigger Values, and Target Values Marco Ranucci, MD, Valeria.

Extracorporeal Membrane Oxygenation in Primary Graft Failure After Heart Transplantation Silvana F. Marasco, FRACS, Matthew Vale, PhD, Vince Pellegrino,

A Closed Perfusion System With Heparin Coating and Centrifugal Pump Improves Cardiopulmonary Bypass Biocompatibility in Elderly Patients Lena Lindholm,

Philip J Wolfson, MD The Annals of Thoracic Surgery

Warfarin Cessation Before Cardiopulmonary Bypass: Lessons Learned from a Randomized Controlled Trial of Oral Vitamin K Richard P. Whitlock, MD, Mark.

Minimally Invasive Extracorporeal Bypass in Minimally Invasive Heart Valve Operations: A Prospective Randomized Trial Hardy Baumbach, MD, Christian J.

P. W. Boonstra, MD, PhD, Y. J. Gu, MD, PhD, C. Akkerman, BSc, J

Cerebrospinal Fluid Markers of Brain Injury, Inflammation, and Blood-Brain Barrier Dysfunction in Cardiac Surgery Björn Reinsfelt, MD, PhD, Sven-Erik.

Continuous pulmonary perfusion during cardiopulmonary bypass prevents lung injury in infants Takaaki Suzuki, MD, Toyoki Fukuda, MD, Tsutomu Ito, MD,

Bashir M Matata, PhD, Andrzej W Sosnowski, MD, Manuel Galiñanes

Leukocyte depletion during cardiac operation: a new approach through the venous bypass circuit Y.John Gu, MD, PhD, A.J de Vries, MD, Paulien Vos, Piet.

Sivelestat Attenuates Lung Injury in Surgery for Congenital Heart Disease With Pulmonary Hypertension Norikazu Nomura, MD, PhD, Miki Asano, MD, PhD,

Effects of Depletion of Leukocytes and Platelets on Cardiac Dysfunction After Cardiopulmonary Bypass Yukio Chiba, Kouichi Morioka, Ryusuke Muraoka, Akio.

Magnesium-supplemented warm blood cardioplegia in patients undergoing coronary artery revascularization Mark Yeatman, Massimo Caputo, MD, Pradeep Narayan,

Susanne Lison, MD, Michael Spannagl, MD, PhD, Wulf Dietrich, MD, PhD

Hedi H Schreurs, Marianne J Wijers, Y

Outcomes of Intraoperative Venoarterial Extracorporeal Membrane Oxygenation Versus Cardiopulmonary Bypass During Lung Transplantation Christian A. Bermudez,

Detrimental Effects of Cardiopulmonary Bypass in Cyanotic Infants: Preventing the Reoxygenation Injury Bradley S. Allen, MD, Shaikh Rahman, MS, Michel.

Synergistic Immunosuppression Caused by High-Dose Methylprednisolone and Cardiopulmonary Bypass Hisanori Mayumi, MD, Qui-Wei Zhang, MD, Atsuhiro Nakashima,

An Analysis of Oxygen Consumption and Oxygen Delivery in Euthermic Infants After Cardiopulmonary Bypass With Modified Ultrafiltration Jia Li, MD, PhD,

Ricardo H Boks, BS, Lex A van Herwerden, MD, PhD, Johanna J

Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery John L Francis, PhD, George J Palmer, MD, Rebecca Moroose,

The effects of heparin and extracorporeal circulation on platelet counts and platelet microaggregation during cardiopulmonary bypass Elijah W. Muriithi,

Relationship Between Antiinflammatory Cytokine Interleukin-10 and Lactate Concentrations in Neonates Undergoing the Arterial Switch Operation Kyrylo.

Stress-Dose Corticosteroid Versus Placebo in Neonatal Cardiac Operations: A Randomized Controlled Trial Pertti K. Suominen, MD, PhD, Juho Keski-Nisula,

Changes in cysteinyl leukotrienes during and after cardiac surgery with cardiopulmonary bypass in patients with and without chronic obstructive pulmonary.

Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia Abdellah Aouifi, MD, Pascale Blanc, MD, Vincent.

Anne H Kuitunen, MD, Lasse J Heikkilä, MD, Markku T Salmenperä, MD

Type A Aortic Dissection With Cold Agglutinin Disease

Efficacy of a new coating material, PMEA, for cardiopulmonary bypass circuits in a porcine model Hitoshi Suhara, MD, Yoshiki Sawa, MD, Motonobu Nishimura,

Antithrombin Administration in Patients With Low Antithrombin Values After Cardiac Surgery: A Randomized Controlled Trial Domenico Paparella, MD, Crescenzia.

Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response Martin Westerberg, MD, Anders.

Effects of perfusion mode on regional and global organ blood flow in a neonatal piglet model Akif Ündar, PhD, Takafumi Masai, MD, Shuang-Qiang Yang,

Benjamin C. Sun, MD, Timothy A. Dickinson, CCP, Eric A

Michael J. Wolf, MD, Kirk R. Kanter, MD, Paul M. Kirshbom, MD, Brian E

Infant cardiopulmonary bypass: a procoagulant state

David L. Joyce, MD The Journal of Thoracic and Cardiovascular Surgery

Anticoagulation with bivalirudin during cardiopulmonary bypass in cardiac surgery Julio C Vasquez, MD, Anna Vichiendilokkul, PharmD, Syed Mahmood, MD,

Platelet and Neutrophil Activation During Cardiac Surgical Procedures: Impact of Cardiopulmonary Bypass David S Morse, David Adams, Barbarajean Magnani

Drew-Anderson technique attenuates systemic inflammatory response syndrome and improves respiratory function after coronary artery bypass grafting Josef.

Interleukin-6 and “complex” cardiac myxoma

Inhibitory effect of milrinone on cytokine production after cardiopulmonary bypass Nobuhiko Hayashida, MD, PhD, Hiroshi Tomoeda, MD, Takeshi Oda, MD,

No benefit of reduced heparinization in thoracic aortic operation with heparin-coated bypass circuits Christian Olsson, MD, Agneta Siegbahn, MD, PhD,

Ronald A. Bronicki, MD, Carl L. Backer, MD, Harris P

Sune Damgaard, MD, PhD, Claus H. Nielsen, MD, PhD, Lars W

Time course of proinflammatory and anti-inflammatory responses after cardiac operation: monocyte HLA-DR expression Y.John Gu, MD, PhD, Willem van Oeveren,

Aprotinin Enhances the Endogenous Release of Interleukin-10 After Cardiac Operations Gary E Hill, Robert P Diego, Alfred H Stammers, Suzanne M Huffman,

Neal S Goldstein, MD The Annals of Thoracic Surgery

Fraser D. Rubens, MD, MS, Gilbert Lavalee, Marc A

Aprotinin in deep hypothermic circulatory arrest

Comparison of Blood Activation in the Wound, Active Vent, and Cardiopulmonary Bypass Circuit Olivier Fabre, MD, PhD, André Vincentelli, MD, PhD, Delphine.

Effects of Methylprednisolone and a Biocompatible Copolymer Circuit on Blood Activation During Cardiopulmonary Bypass Fraser D. Rubens, MD, Howard Nathan,

Factors influencing intensive care unit length of stay after surgery for acute aortic dissection type A Daniel Hoefer, MD, Elfriede Ruttmann, MD, Markus.

Leukocytosis and Increased Risk of Atrial Fibrillation After General Thoracic Surgery David Amar, MD, Anuj Goenka, BS, Hao Zhang, MD, Bernard Park, MD,

Karl A. Bocchieri, BS, CCP, S. Jacob Scheinerman, MD, L

Safety of low hematocrits during cardiopulmonary bypass

Y.John Gu, MD, PhD, Piet W. Boonstra, MD, PhD, Willem van Oeveren, PhD

A randomized trial of antithrombin concentrate for treatment of heparin resistance Mathew R Williams, MD, Alyssa B D’Ambra, BA, James R Beck, Talia B.

Thrombophilic Variables Do Not Increase the Generation or Procoagulant Activity of Thrombin During Cardiopulmonary Bypass Peter Raivio, MD, Jari Petäjä,

Presentation transcript:

Clinical performance and biocompatibility of poly(2-methoxyethylacrylate)—coated extracorporeal circuits Serdar Gunaydin, MD, Bora Farsak, MD, Mustafa Kocakulak, PhD, Tamer Sari, BSc, Cem Yorgancioglu, MD, Yaman Zorlutuna, MD The Annals of Thoracic Surgery Volume 74, Issue 3, Pages 819-824 (September 2002) DOI: 10.1016/S0003-4975(02)03796-7

Fig 1 Trend in hematologic variables throughout the five time periods of the study. (A) White blood cell (WBC) count, (B) platelet count, and (C) fibrinogen levels. (CPB = cardiopulmonary bypass; ICU = intensive care unit; ∗p < 0.05, group 1 [□] versus group 2 [■]). The Annals of Thoracic Surgery 2002 74, 819-824DOI: (10.1016/S0003-4975(02)03796-7)

Fig 2 Trend in (A) serum protein and (B) serum albumin levels throughout the five time periods of the study. (CPB = cardiopulmonary bypass; ICU = intensive care unit; ∗p < 0.05, group 1 [□] versus group 2 [■].) The Annals of Thoracic Surgery 2002 74, 819-824DOI: (10.1016/S0003-4975(02)03796-7)

Fig 3 Serum interleukin-6 (IL-6) levels throughout the five time periods of the study. (CPB = cardiopulmonary bypass; ICU = intensive care unit; ∗p < 0.01, group 1 [□] versus group 2 [■].) The Annals of Thoracic Surgery 2002 74, 819-824DOI: (10.1016/S0003-4975(02)03796-7)

Fig 4 Serum levels of (A) complement fragment C3a and (B) complement fragment C4d throughout the five time periods of the study. (CPB = cardiopulmonary bypass; ICU = intensive care unit; ∗p < 0.05 [C3a], group 1 [□] versus group 2 [■]; ∗ = p < 0.01 [C4d], group 1 [□] versus group 2 [■].) The Annals of Thoracic Surgery 2002 74, 819-824DOI: (10.1016/S0003-4975(02)03796-7)